Patent · US Active

Method and composition for treating rhinitis

US9980959B2 · kind B2 · utility

0Cited by

22References

3Claims

0Family size

Assignee

Biolipox AB · SE

Inventors

Lena Pereswetoff-Morath · Spånga, SE
Anders Carlsson · Lund, SE

Key dates

Filing date	Apr 11, 2012
Grant date	May 29, 2018
Priority date	—
Expiry date	Jan 27, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S977/907
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is provided pharmaceutical compositions for the treatment of rhinitis by, for example, nasal or ocular administration comprising zwitterionic cetirizine, a polar lipid liposome and a pharmaceutical acceptable aqueous carrier. The compositions are preferably homogeneous in their nature.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.